88 related articles for article (PubMed ID: 31692885)
1. Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2019 Oct; 10(58):6285. PubMed ID: 31692885
[TBL] [Abstract][Full Text] [Related]
2. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
[TBL] [Abstract][Full Text] [Related]
3. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
[TBL] [Abstract][Full Text] [Related]
4. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
[TBL] [Abstract][Full Text] [Related]
5. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
[TBL] [Abstract][Full Text] [Related]
6. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Meng S; Wang G; Lu Y; Fan Z
Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
[TBL] [Abstract][Full Text] [Related]
7. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
8. Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Arundhathi A; Chuang WH; Chen JK; Wang SE; Shyr YM; Chen JY; Liao WN; Chen HW; Teng YM; Pai CC; Wang CH
Oncotarget; 2019 Jan; 10(4):558. PubMed ID: 30728905
[TBL] [Abstract][Full Text] [Related]
9. Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Tsai CH; Tsai HC; Huang HN; Hung CH; Hsu CJ; Fong YC; Hsu HC; Huang YL; Tang CH
Oncotarget; 2018 Oct; 9(85):35598. PubMed ID: 30473753
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
[TBL] [Abstract][Full Text] [Related]
11. Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival.
Maimouni S; Lee MH; Sung YM; Hall M; Roy A; Ouaari C; Hwang YS; Spivak J; Glasgow E; Swift M; Patel J; Cheema A; Kumar D; Byers S
Oncotarget; 2021 Oct; 12(22):2305-2306. PubMed ID: 34733422
[TBL] [Abstract][Full Text] [Related]
12. Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
An F; Gong G; Wang Y; Bian M; Yu L; Wei C
Oncotarget; 2018 May; 9(37):24871. PubMed ID: 29873327
[TBL] [Abstract][Full Text] [Related]
13. Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.
Zhou P; Zhang R; Wang Y; Xu D; Zhang L; Qin J; Su G; Feng Y; Chen H; You S; Rui W; Liu H; Chen S; Chen H; Wang Y
Oncotarget; 2021 Jan; 12(1):61-62. PubMed ID: 33456714
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
[TBL] [Abstract][Full Text] [Related]
15. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun.
Bitomsky N; Böhm M; Klempnauer KH
Oncogene; 2004 Sep; 23(45):7484-93. PubMed ID: 15334056
[TBL] [Abstract][Full Text] [Related]
16. Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells.
Fernandez-Carrascal A; Garcia-Algar M; Nazarenus M; Torres-Nuñez A; Guerrini L; Feliu N; Parak WJ; Garcia-Rico E; Alvarez-Puebla RA
Oncotarget; 2019 Nov; 10(61):6643. PubMed ID: 31762944
[TBL] [Abstract][Full Text] [Related]
17. Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach.
Xiao Z; Sperl B; Gärtner S; Nedelko T; Stacher-Priehse E; Ullrich A; Knyazev PG
Oncotarget; 2021 Aug; 12(17):1734-1735. PubMed ID: 34434503
[TBL] [Abstract][Full Text] [Related]
18. Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B; Martín-Rodríguez P; Díaz-Chico JC; McNaughton-Smith G; Jiménez-Alonso S; Hueso-Falcón I; Montero JC; Blanco R; León J; Rodríguez-González G; Estévez-Braun A; Pandiella A; Díaz-Chico BN; Fernández-Pérez L
Oncotarget; 2018 Aug; 9(63):32272. PubMed ID: 30181817
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Egr2 and Egr4 protects rat brains against ischemic stroke by downregulating JNK signaling pathway.
Niu RN; Shang XP; Teng JF
Biochimie; 2018 Jun; 149():62-70. PubMed ID: 29580816
[TBL] [Abstract][Full Text] [Related]
20. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo.
May GH; Funk M; Black EJ; Clark W; Hussain S; Woodgett JR; Gillespie DA
Curr Biol; 1998 Jan; 8(2):117-20. PubMed ID: 9427647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
